Price Targets For NUS Stock Cut In Half Following Forecast Change

Short interest has been rising on Nu Skin

by Josh Selway

Published on Jul 17, 2019 at 9:24 AM

Nu Skin Enterprises, Inc. (NYSE:NUS) is one of the biggest pre-market losers this morning, last seen 21.9% in the red shortly before the open after the direct selling company made a sizable adjustment to the downside in its full-year forecast. NUS told investors the change is due to a number of factors, most notably weakness in China, but also "media scrutiny" that has hurt its standing with consumers. A few analysts have weighed in on Nu Skin, as well.

Jefferies downgraded its opinion to "hold" from "buy" and cut its price target in half to $40, saying it did not see the announcement coming. D.A. Davidson also lowered its rating to "hold" and moved its price target to $38 from $88, and Stifel gave a price-target cut to $37 from $45. There were already two "sell" or "strong sell" ratings on the stock coming into today.

NUS was down roughly 50% from its August peak just shy of $89, and a breakout attempt back in May quickly disappeared after coming up a few points shy of the 200-day moving average. The shares hit a three-year low of $43.65 just yesterday.

Many bears were prepared for additional losses, based on data from the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Almost nine puts were bought to open for every call during the past 10 days,and peak open interest is at the September 40 put. Meanwhile, short interest popped 21.5% in the last two reporting periods.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Cannabis Stock Rally Cut Short after Downgrade
Aurora Cannabis did receive a price-target hike from Jefferies, though
Vaccines, China Trigger Roller Coaster Week for Stocks
Moderna's vaccine captured the attention of Wall Street
Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.